For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Research and development | 306,970 | |||
| General and administrative | 107,337 | |||
| Total operating expenses | 414,307 | |||
| Loss from operations | -414,307 | |||
| Change in fair value of related party revenue share liability | -55,220 | |||
| Interest income and other income (expense), net | 44,735 | |||
| Total other income (expense), net | -10,485 | |||
| Loss before income taxes | -424,792 | |||
| Income tax provision | 585 | |||
| Net loss | -425,377 | |||
| Unrealized gains (losses) on marketable securities | 2,412 | |||
| Comprehensive loss | -422,965 | |||
| Basic EPS | -5.85 | |||
| Diluted EPS | -5.85 | |||
| Basic Average Shares | 72,686,749 | |||
| Diluted Average Shares | 72,686,749 | |||
Nuvalent, Inc. (NUVL)
Nuvalent, Inc. (NUVL)